Cost Effectiveness [qnco]
therapy [ftcn]
treatment [ftcn]
Resistant [ftcn]
Hypertension [dsyn]
European [popg]
setting [ftcn]
Objective [inpr]
Purpose [ftcn]
Study [mnob]
To [qlco]
simulate [bodm]
Cost Effectiveness [qnco]
Long-term [tmco]
Clinical [qlco]
Performance [inbe]
NEO [gngm]
System [ftcn]
treatment [ftcn]
Resistant [ftcn]
Hypertension [dsyn]
Compared [acty]
Optimal [qlco]
Medical [ftcn]
treatment [ftcn]
Methods [inpr]
Decision [menp]
Model [inpr]
Combination [qlco]
Tree, Decision [inpr]
Markov Process [qnco]
To [qlco]
Evaluate [ftcn]
Cost Effectiveness [qnco]
Clinical [qlco]
Effectiveness [qlco]
Based [ftcn]
Result [ftcn]
randomized controlled trial [inpr, resa]
placebo [topp]
Follow-up [fndg]
HT [geoa]
Trial [resa]
Cost Effectiveness [qnco]
Model [inpr]
German [popg]
Patients [podg]
High [qlco]
sbp [diap]
Levels [qlco]
Increased [qnco]
Risk [qlco]
Myocardial Infarction [dsyn]
Stroke [dsyn]
Heart failure [dsyn]
Renal Disease, End-Stage [dsyn]
Result [ftcn]
simulated [bodm]
Cohort [popg]
Old [tmco]
Patients [podg]
High Risk [qlco]
end organ damage [dsyn]
therapy [ftcn]
Generated [acty]
Additional [ftcn]
Life [idcn]
Additional [ftcn]
Quality-Adjusted Life Years [tmco]
Incremental [qnco]
Cost [qnco]
Compared [acty]
Medical [ftcn]
Management [ocac]
Estimated [qnco]
To [qlco]
Cost Effectiveness [qnco]
Compared [acty]
Optimal [qlco]
Medical [ftcn]
treatment [ftcn]
Incremental [qnco]
Cost Effectiveness [qnco]
Ratio [qnco]
QALY [tmco]
Model [inpr]
Reduced [qlco]
Rate [acty]
Myocardial Infarction [dsyn]
Stroke [dsyn]
Heart failure [dsyn]
Renal Disease, End-Stage [dsyn]
Cost Effectiveness [qnco]
Young [tmco]
Patients [podg]
Resistant [ftcn]
Hypertension [dsyn]
Patients [podg]
risk factors [qnco]
end organ damage [dsyn]
Conclusion [idcn]
cost treatment [qnco]
effective [qlco]
Compared [acty]
Optimal [qlco]
Medical [ftcn]
Management [ocac]
Patients [podg]
Resistant [ftcn]
Hypertension [dsyn]
